Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
The manufacturing conditions of Xgeva / Prolia biosimilar from the CHO stable cell line need to be optimized by clients.
The cheapest research grade denosumab biosimilar protein (1 mg for >$30) is also available.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Denosumab (trade name Xgeva, Prolia, Amgen), a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.
C004: Xgeva / Prolia Biosimilar Stable Cell Line (CHO)
The yield of Xgeva / Prolia biosimilar from the CHO stable cell line was above 9.0 g/L in a 15 liter manufacturing.
The Xgeva / Prolia biosimilar stable cell line alone can be transfered alone or together with the technology of process development and/or antibody purification.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.